OPOWM
DWTX

One Plus One Wealth Management’s Dogwood Therapeutics DWTX Stock Holding History

One Plus One Wealth Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-800
Closed -$3.4K – 97
2024
Q3 		$3.4K Buy
800
+400
+100% +$2.07K ﹤0.01% 87
2024
Q2 		$2.15K Buy
+400
New +$3.46K ﹤0.01% 93

Other funds holding DWTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

One Plus One Wealth Management's DWTX Position: Q4 2024 in Review

One Plus One Wealth Management sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 800 shares — an estimated $3.4K sold.

One Plus One Wealth Management first reported a position in DWTX in Q2 2024 and held it in 2 quarters. The position peaked at $3.4K in Q3 2024. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • One Plus One Wealth Management reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • One Plus One Wealth Management sold 800 Dogwood Therapeutics shares in Q4 2024, an estimated $3.4K.
  • One Plus One Wealth Management first reported a position in Dogwood Therapeutics in Q2 2024 and held it in 2 quarters.
  • One Plus One Wealth Management's Dogwood Therapeutics position peaked at $3.4K in Q3 2024.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on One Plus One Wealth Management's 13F filing for Q4 2024, filed 29 Jan 2025.